Estrogen receptor gene polymorphisms in Japanese patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 26, Issue 5, 2008, Pages 914-917

  Hoshi, Masaya ^a,b   Yasuoka, Hidekata ^b   Kuwana, Masataka ^b  

^a Den en chofu Animal Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endocrine disrupting chemical; Estrogen; Scleroderma; Single nucleotide polymorphism

Indexed keywords

ANTINUCLEAR ANTIBODY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEART DISEASE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 57249111628     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. MEDSGER TA JR: SystCmic sclerosis (scleroderma): clinical aspects. In KOOPMAN WJ (Ed): Arthritis and Allied Conditions. 13th ed. Baltimore, Williams & Wilkins 1997: 1433-64.
2. ASSASSI S, TAN FK: Uenetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays. Curr Opin Rheumatol 2005; 17: 761-7.
3. KUWANA M, INOKO H, KAMEDA H et al.: Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern Med 1999; 38: 336-44.
4. NIETERT PJ, SIEVER RM: Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 2000; 12: 520-6.
5. CALVANI N, SILVESTRIS F, DAMMACCO F: Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Ann Ital Med Int 2001; 16: 175-8.
6. KETTANEH A, AL MOUFTI O, TIEV KP et al.: Occupational exposure to solvents and gender-related risk of systemic sclerosis: A metaanalysis of case-control studies. J Rheumatol 2007; 34: 97-103.
7. WARING RH, HARRIA RM: Endocrine disrupters: a human risk? Mol Cell Endocrinol 2005; 244: 2-9.
8. ENMARK E, GUSTAFSSON JÅ: Oestrogen receptors - an overview. J Intern Med 1999; 246: 133-8.
9. KOBAYASHI S, INOUE S, HOSOI T, OUCHI Y, SHIRAKI M, ORIMO H: Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996; 11: 306-11.
10. ANDERSEN TI, HEIMDAL KR, SKREDE M, TVEIT K, BERG K, BORRESEN AL: Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994; 94: 665 -70.
11. SCHUIT SC, OEI HH, WITTEMAN JC et al.: Estrogen receptor a gene polymorphisms and risk of myocardial infarction. JAMA 2004; 291: 2969-77.
12. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
13. KUWANA M, KABURAKI J, OKANO Y, TOJO T, HOMMA M: Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994; 37: 75-83.
14. LIAO WX, ROY AC, CHAN CA, ARULKUMARAN S, RATNAM SS: A new molecular variant of luteinizing hormone associated with female infertility. Fertil Steril 1998; 69: 102-6.
15. INOKO H, OTA M: PCR-RFLP. IN HUI, KM, BIDWELL J (Eds.): Handbook of HLA typing techniques. Boca Raton, CRC Press 1993: 9-70.
16. KAMEDA H, PANDEY JP, KABURAKI J, INOKO H, KUWANA M: Immunoglobulin allotype gene polymorphisms in systemic sclerosis: Interactive effect of MHC class II and KM genes on anticentromere antibody production. Ann Rheum Dis 1998; 57: 366-70.
17. LIU ZH, CHENG ZH, GONG RJ, LIU H, LIU D, LI LS: Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese. Nephron 2002; 90: 174-80.
18. LEE Y J, SHIN KS, KANG SW et al.: Association of the oestrogen receptor gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1244-9.
19. JOHANSSON M, ARLESTIG L, MOLLER B, SMEDBY T, RANTAPAA-DAHLQVIST S: Oestrogen receptor a gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 1611-7.
20. COHEN-SOLAL JF, JEGANATHAN V, GRIMALDI CM, PEEVA E, DIAMOND B: Sex hormones and SLE: Influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol 2006; 305: 67-88.
21. BERETTA L, CARONNI M, ORIGGI L, PONTI A, SANTANIELLO A, SCORZA R: Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol 2006; 35: 468-71.
22. LEKAKIS J, MAVRIKAKIS M, PAPAMICHAEL C et al.: Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon. Am Heart J 1998; 136: 905-12.
23. NIETERT PJ, SUTHERLAND SE, SILVER RM, PANDEY JP, DOSEMECI M: Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol 1999; 26: 2369-72.
24. HERRINGTON DM, HOWARD TD, BROSNIHAN KB et al.: Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105: 1879-82.
25. SHEARMAN AM, CUPPLES LA, DEMISSIE S et al.: Association between estrogen receptor gene variation and cardiovascular disease. JAMA 2003; 290: 2263-70.
26. HERRINGTON DM, HOWARD TD, HAWKINS GA et al.: Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002; 346: 967-74.
27. PARE G, KRUST A, KARAS RH et al.: Estrogen receptor a mediates the protective effects of estrogen against vascular injury. Circ Res 2002; 90: 1087-92.